Discussed the need for Congressional oversight of CMS to ensure enforcement of the preventive services mandate, specifically requiring coverage of bowel preparation medications without cost-sharing when used for colonoscopy screenings.
2025 · 1st Quarter (Jan 1 - Mar 31)
SEBELA PHARMACEUTICALS
Filed by THE KPM GROUP DC LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- THE KPM GROUP DC LLC
- Client
- SEBELA PHARMACEUTICALS
- Filing UUID
- 283db832-5cb9-4f14-bd51-f16665880b29
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.